Multidisciplinary approach to breast cancer diagnosed during pregnancy: Maternal and neonatal outcomes

Octavi Córdoba, Elisa Llurba, Cristina Saura, Isabel Rubio, Queralt Ferrer, Javier Cortés, Jordi Xercavins

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

Aim: We assessed maternal and neonatal outcome in women diagnosed with breast cancer during pregnancy. Patients and methods: Retrospective single-centre cohort study of 25 consecutive pregnant women (mean age 36 years) diagnosed and treated for breast cancer between 2000 and 2011. Management was individualized according to type of tumor and time of gestation at diagnosis. Results: Twelve patients were diagnosed during the second trimester. BI-RADS category <3 mammographic lesions were diagnosed in 7 patients. A suspicious area was detected by ultrasound in 20 of 21 women who underwent ultrasound studies. Nineteen patients had positive hormone receptors and 7 sobreexpressed HER2. One patient was in stage 0, 8 in stage I, 8 in stage II, 3 in stage III and 5 in stage IV. Four patients decided voluntarily to legally terminate their pregnancies, one had a spontaneous miscarriage and in three patients, pregnancy was interrupted at the end of the third trimester before oncological treatment. Eleven patients were treated with chemotherapy during pregnancy after the second trimester using anthracycline-based regimens. In five patients the pregnancy was ended before 34 weeks of gestation. Nine patients had gestation-related complications, including preterm labor, pneumonia, increase in velocity of the middle cerebral artery, oligohydramnios, preeclampsia, extreme prematurity, intrauterine growth restriction, dyspnea, spontaneous miscarriage and chemotherapy-related granulocytopenia. Betamethasone to stimulate fetal lung maturation was used in 6 patients. Conclusion: Breast cancer women diagnosed during pregnancy presented a high number of complications unrelated to antineoplastic treatment. A multidisciplinary team approach is necessary for satisfactory neonatal results. © 2012 Elsevier Ltd.
Original languageEnglish
Pages (from-to)515-519
JournalBreast
Volume22
Issue number4
DOIs
Publication statusPublished - 1 Aug 2013

Keywords

  • Antineoplastic combined chemotherapy protocols
  • Breast neoplasms
  • Fetus/drug effects
  • Postpartum period
  • Pregnancy complications

Fingerprint Dive into the research topics of 'Multidisciplinary approach to breast cancer diagnosed during pregnancy: Maternal and neonatal outcomes'. Together they form a unique fingerprint.

Cite this